Novo Nordisk Stock Soars 10% After FDA Approves Wegovy Tablet, Boosting Growth Outlook
New Nordisk’s stock jumps 10 % as FDA approves Wegovy tablet, opening a new U.S. revenue stream and boosting investor optimism.
3 minutes to read
Novo Nordisk B
New Oral Wegovy Pill Gets FDA & EMA Approval – Boosts Novo Nordisk’s Weight‑Management Market
Novo Nordisk’s first oral GLP‑1 weight‑management pill, Wegovy® pill, hits FDA and EMA approvals, expands to India, and could shift its stock outlook.
3 minutes to read
Novo Nordisk B Announces Major Board Overhaul Amid Governance Dispute with Novo Nordisk Foundation
Novo Nordisk B, a leading Danish pharmaceutical company, is undergoing a major governance overhaul after a prolonged dispute with its primary shareholder, the Novo Nordisk Foundation, over the future composition and strategic direction of the board.
3 minutes to read
Novo Nordisk Shares Tumble Amid U.S. Drug Pricing Policy Changes and FDA Approval of Rybelsus
Novo Nordisk’s stock price plummeted 6.4% after former US President Donald Trump announced a plan to reduce tariffs on fertility treatments and the medication Ozempic, potentially undermining the company’s pricing power in the US market.
2 minutes to read